Empyema n = 10 | Empyema + NP n = 25 | p-value | |
Medical and surgical management | |||
IV β-lactamines | 10/10 (100.0%) | 25/25 (100.0%) | 1 |
Duration (d) | 12.5 [8 to 22] | 12 [6 to 56] | 0.69 |
Oral β-lactamines after IV treatment | 10/10 (100.0%) | 22/24 (91.7%) | 1 |
Duration (d) | 16 [7 to 30] | 21 [9 to 45] | 0.15 |
O2 requirement | 7/10 (70.0%) | 10/25 (40.0%) | 0.15 |
Duration (d) | 10 [2 to 10] | 8 [2 to 40] | 0.59 |
Chest tube | 10/10 (100.0%) | 24/25 (96.0%) | 1.00 |
Insertion delay after admission (d) | 2 [1 to 15] | 2 [0 to 8] | 0.64 |
Duration (d) | 7 [3 to 12] | 5 [2 to 128] | 0.67 |
Intrapleural urokinase | 4/5 (80.0%) | 3/13 (23.1%) | 0.047 |
VATS | 8/10 (80.0%) | 21/25 (84.0%) | 1.000 |
Outcomes | |||
Fever duration (d) | 15 [12 to 28] | 14 [9 to 36] | 0.73 |
Fever duration after admission (d) | 10 [3 to 25] | 9 [3 to 30] | 0.74 |
ICU admission | 6/10 (60.0%) | 12/25 (48.0%) | 0.71 |
ICU length of stay (d) | 3 [1 to 5] | 2 [1 to 33] | 0.92 |
Hospital length of stay (d) | 15 [9 to 42] | 15 [8 to 140] | 0.71 |
Delay of X-ray normalization (d) | 288 | 126 | 0.28 |